최소 단어 이상 선택하여야 합니다.
최대 10 단어까지만 선택 가능합니다.
다음과 같은 기능을 한번의 로그인으로 사용 할 수 있습니다.
NTIS 바로가기International journal of oncology, v.46 no.6, 2015년, pp.2309 - 2316
DE XU, HONG (School of Pharmaceutical Science, Zhengzhou University, Zhengzhou 450001, P.R. China) , CHO, SOON-CHANG (NaturePureKorea Inc., Jeonnam 517-8-3, Republic of Korea) , BANG, MI-AE (Research Development Team, Jeonnam Biofood Technology Center, Jeonnam, Naju 520-330, Republic of Korea) , BAE, CHUN-SIK (College of Veterinary Medicine, Chonnam National University, Gwangju 500-757, Republic of Korea) , CHOI, YEONSHIK (Department of Bio Medical Analysis, Korea Polytechnic College, Nonsan, Chungnam 320-905, Republic of Korea) , LI, YONG-CHUN (NaturePureKorea Inc., Jeonnam 517-8-3, Republic of Korea) , LIM, SEUNG-KIL (Department of Exercise Prescription, Dongshin University, Naju, Jeonnam 520-714, Republic of Korea) , SHIM, JAEGAL (Comparative Biomedicine Research Branch, National Cancer Center, Goyang-si, Gyeonggi-do 411-769, Republic of Korea) , PARK, DAE-HUN (Department of Oriental Medicine Materials, Dongshin University, Naju, Jeonnam 520-714, Republic of Korea)
The World Health Organization (WHO) has reported that cancer is one of the most prevalent diseases and a leading cause of death worldwide. Many anticancer drug development studies have been pursued over the last few decades and several viable drugs have been discovered, such as paclitaxel, topotecan...
1 The World Health Organization Cancer, Fact Sheet No. 297 2 2014
2 International Agency for Research on Cancer Estimated cancer incidence, mortality and prevalence worldwide in 2012 Globocan 2012 2012
3 Gupta SC Sundaram C Reuter S Aggarwal BB Inhibiting NF-κB activation by small molecules as a therapeutic strategy Biochim Biophys Acta 1799 775 787 2010 10.1016/j.bbagrm.2010.05.004 2955987 --> 20493977
4 Luo JL Kamata H Karin M IKK/NF-kappaB signaling: balancing life and death - a new approach to cancer therapy J Clin Invest 115 2625 2632 2005 10.1172/JCI26322 1236696 --> 16200195
5 Kozakai N Kikuchi E Hasegawa M Suzuki E Ide H Miyajima A Horiguchi Y Nakashima J Umezawa K Shigematsu N Oya M Enhancement of radiosensitivity by a unique novel NF-κB inhibitor, DHMEQ, in prostate cancer Br J Cancer 107 652 657 2012 10.1038/bjc.2012.321 3419964 --> 22805327
6 Sun XF Zhang H NFκB and NFκBI polymorphisms in relation to susceptibility of tumour and other diseases Histol Histopathol 22 1387 1398 2007 17701919
7 St-Germain ME Gagnon V Parent S Asselin E Regulation of COX-2 protein expression by Akt in endometrial cancer cells is mediated through NF-kappaB/IkappaB pathway Mol Cancer 3 1 11 2004 10.1186/1476-4598-3-7 14723797
8 Monks NR Pardee AB Targeting the NF-kappa B pathway in estrogen receptor negative MDA-MB-231 breast cancer cells using small inhibitory RNAs J Cell Biochem 98 221 233 2006 10.1002/jcb.20789 16408291
9 Jang BC Sanchez T Schaefers HJ Trifan OC Liu CH Creminon C Huang CK Hla T Serum withdrawal-induced post-transcriptional stabilization of cyclooxygenase-2 mRNA in MDA-MB-231 mammary carcinoma cells requires the activity of the p38 stress-activated protein kinase J Biol Chem 275 39507 39515 2000 10.1074/jbc.M003224200 10993880
10 Karin M Yamamoto Y Wang QM The IKK NF-kappa B system: a treasure trove for drug development Nat Rev Drug Discov 3 17 26 2004 10.1038/nrd1279 14708018
11 Orlowski RZ Baldwin AS Jr NF-kappaB as a therapeutic target in cancer Trends Mol Med 8 385 389 2002 10.1016/S1471-4914(02)02375-4 12127724
12 Guttridge DC Albanese C Reuther JY Pestell RG Baldwin AS Jr NF-kappaB controls cell growth and differentiation through transcriptional regulation of cyclin D1 Mol Cell Biol 19 5785 5799 1999 84428 --> 10409765
13 Dannenberg AJ Altorki NK Boyle JO Dang C Howe LR Weksler BB Subbaramaiah K Cyclo-oxygenase 2: a pharmacological target for the prevention of cancer Lancet Oncol 2 544 551 2001 10.1016/S1470-2045(01)00488-0 11905709
14 Thun MJ Henley SJ Patrono C Nonsteroidal anti-inflammatory drugs as anticancer agents: mechanistic, pharmacologic, and clinical issues J Natl Cancer Inst 94 252 266 2002 10.1093/jnci/94.4.252 11854387
15 Liu B Shi ZL Feng J Tao HM Celecoxib, a cyclooxygenase-2 inhibitor, induces apoptosis in human osteosarcoma cell line MG-63 via down-regulation of PI3K/Akt Cell Biol Int 32 494 501 2008 10.1016/j.cellbi.2007.10.008 18078766
16 Leng J Han C Demetris AJ Michalopoulos GK Wu T Cyclooxygenase-2 promotes hepatocellular carcinoma cell growth through Akt activation: evidence for Akt inhibition in celecoxib-induced apoptosis Hepatology 38 756 768 2003 10.1053/jhep.2003.50380 12939602
17 Half E Sun Y Sinicrope FA Anti-EGFR and ErbB-2 antibodies attenuate cyclooxygenase-2 expression and cooperatively inhibit survival of human colon cancer cells Cancer Lett 251 237 246 2007 10.1016/j.canlet.2006.11.020 17189670
18 Park MK Hwang SY Kim JO Kwack MH Kim JC Kim MK Sung YK NS398 inhibits the growth of Hep3B human hepatocellular carcinoma cells via caspase-independent apoptosis Mol Cells 17 45 50 2004 15055526
19 Reddy L Odhav B Bhoola KD Natural products for cancer prevention: a global perspective Pharmacol Ther 99 1 13 2003 10.1016/S0163-7258(03)00042-1 12804695
20 Giovino GA The tobacco epidemic in the United States Am J Prev Med 33 S318 S326 2007 10.1016/j.amepre.2007.09.008 18021906
21 Aggarwal BB Shishodia S Molecular targets of dietary agents for prevention and therapy of cancer Biochem Pharmacol 71 1397 1421 2006 10.1016/j.bcp.2006.02.009 16563357
22 Boileau TW Liao Z Kim S Lemeshow S Erdman JW Jr Clinton SK Prostate carcinogenesis in N-methyl-N-nitrosourea (NMU)-testosterone-treated rats fed tomato powder, lycopene, or energy-restricted diets J Natl Cancer Inst 95 1578 1586 2003 10.1093/jnci/djg081 14600090
23 Halicka D Ita M Tanaka T Kurose A Darzynkiewicz Z Biscoclaurine alkaloid cepharanthine protects DNA in TK6 lymphoblastoid cells from constitutive oxidative damage Pharmacol Rep 60 93 100 2008 2577765 --> 18276990
24 Kikukawa Y Okuno Y Tatetsu H Nakamura M Harada N Ueno S Kamizaki Y Mitsuya H Hata H Induction of cell cycle arrest and apoptosis in myeloma cells by cepharanthine, a biscoclaurine alkaloid Int J Oncol 33 807 814 2008 18813795
25 Meng LH Zhang H Hayward L Takemura H Shao RG Pommier Y Tetrandrine induces early G1 arrest in human colon carcinoma cells by down-regulating the activity and inducing the degradation of G1-S-specific cyclin-dependent kinases and by inducing p53 and p21 Cip1 Cancer Res 64 9086 9092 2004 10.1158/0008-5472.CAN-04-0313 15604277
26 Park D-H Xu HD Shim J Li Y-C Lee J-H Cho S-C Han S-S Lee Y-L Lee M-J Kwon S-W Stephania delavayi Diels. inhibits breast carcinoma proliferation through the p38MAPK/ NF-κB/COX-2 pathway Oncol Rep 26 833 841 2011 21725607
27 Nawawi A Nakamura N Meselhy MR Hattori M Kurokawa M Shiraki K Kashiwaba N Ono M In vivo antiviral activity of Stephania cepharantha against herpes simplex virus type-1 Phytother Res 15 497 500 2001 10.1002/ptr.881 11536378
28 Ma CM Nakamura N Hattori M Kawahata T Otake T Inhibitory effects of triterpene-azidothymidine conjugates on proliferation of human immunodeficiency virus type 1 and its protease Chem Pharm Bull (Tokyo) 50 877 880 2002 10.1248/cpb.50.877 12045355
29 Ma CM Nakamura N Miyashiro H Hattori M Komatsu K Kawahata T Otake T Screening of Chinese and Mongolian herbal drugs for anti-human immunodeficiency virus type 1 (HIV-1) activity Phytother Res 16 186 189 2002 10.1002/ptr.922 11933126
30 Baba M Inhibitors of HIV-1 gene expression and transcription Curr Top Med Chem 4 871 882 2004 10.2174/1568026043388466 15134546
31 Liu WK Wang XK Che CT Cytotoxic effects of sinococuline Cancer Lett 99 217 224 1996 10.1016/0304-3835(95)04065-X 8616827
32 Carraz M Jossang A Rasoanaivo P Mazier D Frappier F Isolation and antimalarial activity of new morphinan alkaloids on Plasmodium yoelii liver stage Bioorg Med Chem 16 6186 6192 2008 10.1016/j.bmc.2008.04.033 18456502
33 Nawawi A Ma C Nakamura N Hattori M Kurokawa M Shiraki K Kashiwaba N Ono M Anti-herpes simplex virus activity of alkaloids isolated from Stephania cepharantha Biol Pharm Bull 22 268 274 1999 10.1248/bpb.22.268 10220283
34 Itokawa H Tsuruoka S Takeya K Mori N Sonobe T Kosemura S Hamanaka T An antitumor morphinane alkaloid, sinococuline, from Cocculus trilobus Chem Pharm Bull 35 1660 1662 1987 10.1248/cpb.35.1660 3652302
35 Chinembiri TN du Plessis LH Gerber M Hamman JH du Plessis J Review of natural compounds for potential skin cancer treatment Molecules 19 11679 11721 2014 10.3390/molecules190811679 25102117
36 Nesaretnam K Meganathan P Tocotrienols: inflammation and cancer Ann NY Acad Sci 1229 18 22 2011 10.1111/j.1749-6632.2011.06088.x 21793834
37 Ganguly A Yang H Cabral F Paclitaxel-dependent cell lines reveal a novel drug activity Mol Cancer Ther 9 2914 2923 2010 10.1158/1535-7163.MCT-10-0552 2978777 --> 20978163
38 Ghosh R Garcia GE Crosby K Inoue H Thompson IM Troyer DA Kumar AP Regulation of Cox-2 by cyclic AMP response element binding protein in prostate cancer: potential role for nexrutine Neoplasia 9 893 899 2007 10.1593/neo.07502 2077880 --> 18030357
39 Kumar AP Bhaskaran S Ganapathy M Crosby K Davis MD Kochunov P Schoolfield J Yeh IT Troyer DA Ghosh R Akt/ cAMP-responsive element binding protein/cyclin D1 network: a novel target for prostate cancer inhibition in transgenic adenocarcinoma of mouse prostate model mediated by Nexrutine, a Phellodendron amurense bark extract Clin Cancer Res 13 2784 2794 2007 10.1158/1078-0432.CCR-06-2974 1948816 --> 17473212
40 van Hogerlinden M Rozell BL Ahrlund-Richter L Toftgard R Squamous cell carcinomas and increased apoptosis in skin with inhibited Rel/nuclear factor-kappaB signaling Cancer Res 59 3299 3303 1999 10416581
41 Miyamoto S Maki M Schmitt MJ Hatanaka M Verma IM Tumor necrosis factor alpha-induced phosphorylation of I kappa B alpha is a signal for its degradation but not dissociation from NF-kappa B Proc Natl Acad Sci USA 91 12740 12744 1994 10.1073/pnas.91.26.12740 45515 --> 7809113
42 Yang G Yu F Fu H Lu F Huang B Bai L Zhao Z Yao L Lu Z Identification of the distinct promoters for the two transcripts of apoptosis related protein 3 and their transcriptional regulation by NFAT and NFkappaB Mol Cell Biochem 302 187 194 2007 10.1007/s11010-007-9440-7 17387583
43 Herrmann JL Beham AW Sarkiss M Chiao PJ Rands MT Bruckheimer EM Brisbay S McDonnell TJ Bcl-2 suppresses apoptosis resulting from disruption of the NF-kappa B survival pathway Exp Cell Res 237 101 109 1997 10.1006/excr.1997.3737 9417872
44 Notarbartolo M Poma P Perri D Dusonchet L Cervello M D’Alessandro N Antitumor effects of curcumin, alone or in combination with cisplatin or doxorubicin, on human hepatic cancer cells. Analysis of their possible relationship to changes in NF-κB activation levels and in IAP gene expression Cancer Lett 224 53 65 2005 10.1016/j.canlet.2004.10.051 15911101
45 Wang CY Mayo MW Korneluk RG Goeddel DV Baldwin AS Jr NF-kappaB antiapoptosis: induction of TRAF1 and TRAF2 and c-IAP1 and c-IAP2 to suppress caspase-8 activation Science 281 1680 1683 1998 10.1126/science.281.5383.1680 9733516
46 Bian X McAllister-Lucas LM Shao F Schumacher KR Feng Z Porter AG Castle VP Opipari AW Jr NF-kappa B activation mediates doxorubicin-induced cell death in N-type neuroblastoma cells J Biol Chem 276 48921 48929 2001 10.1074/jbc.M108674200 11679590
47 Ryan KM Ernst MK Rice NR Vousden KH Role of NF-kappaB in p53-mediated programmed cell death Nature 404 892 897 2000 10.1038/35009130 10786798
48 Chan FK Hung LC Suen BY Wu JC Lee KC Leung VK Hui AJ To KF Leung WK Wong VW Chung SC Sung JJ Celecoxib versus diclofenac and omeprazole in reducing the risk of recurrent ulcer bleeding in patients with arthritis N Engl J Med 347 2104 2110 2002 10.1056/NEJMoa021907 12501222
*원문 PDF 파일 및 링크정보가 존재하지 않을 경우 KISTI DDS 시스템에서 제공하는 원문복사서비스를 사용할 수 있습니다.
저자가 APC(Article Processing Charge)를 지불한 논문에 한하여 자유로운 이용이 가능한, hybrid 저널에 출판된 논문
※ AI-Helper는 부적절한 답변을 할 수 있습니다.